SynthesisDiabetes, obesity & metabolism2021

Efficacy and safety of iGlarLixi versus IDegAsp: Results of a systematic literature review and indirect treatment comparison.

Philip D Home et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.